Silence Therapeutics plc (SLNCF)

Silence Therapeutics Revenue

Silence Therapeutics had revenue of $422.00K in the quarter ending March 31, 2026, with 197.18% growth. This brings the company's revenue in the last twelve months to $839.00K, down -96.86% year-over-year. In the year 2025, Silence Therapeutics had annual revenue of $559.00K, down -98.71%.

• Revenue (ttm): 839.00K
• Revenue Growth: -96.86%
• P/S Ratio: 338.36
• Revenue / Employee: 9.53K
• Employees: 88
• Market Cap: 283.88M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	559.00K	-42.70M	-98.71%
Dec 31, 2024	43.26M	11.62M	36.71%
Dec 31, 2023	31.64M	9.99M	46.12%
Dec 31, 2022	21.66M	4.87M	29.01%
Dec 31, 2021	16.79M	9.29M	124.07%
Dec 31, 2020	7.49M	7.17M	2,215.11%
Dec 31, 2019	323.57K	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	21.62K	-928.69K	-97.72%
Dec 31, 2016	950.31K	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	23.37K	-170.40K	-87.94%
Dec 31, 2013	193.77K	-70.63K	-26.71%
Dec 31, 2012	264.40K	-812.57K	-75.45%
Dec 31, 2011	1.08M	-2.61M	-70.75%
Dec 31, 2010	3.68M	893.28K	32.03%
Dec 31, 2009	2.79M	-435.52K	-13.51%
Dec 31, 2008	3.22M	-	-

Data Source: Fiscal.ai Last updated: Mar 31, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 6, 2026

Data Sources Report a data error